• CARGO Therapeutics Inc CRGX.OQ reported a quarterly adjusted loss of $1.77​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -87 cents. The mean expectation of five analysts for the quarter was for a loss of 72 cents per share. Wall Street expected results to range from $-1.05 to -37 cents per share.

• Reported revenue was zero​; analysts expected zero.

• CARGO Therapeutics Inc's reported EPS for the quarter was a loss of $1.77​.

• The company reported a quarterly loss of $84.5 million.

• CARGO Therapeutics Inc shares had fallen by 1.2% this quarter and lost 72.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 4.4% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "hold"

• Wall Street's median 12-month price target for CARGO Therapeutics Inc is $5.50

This summary was machine generated from LSEG data May 12 at 09:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)